Is your Lab Ready for the Future of Blood Culture Testing?
We're preparing the next generation of solutions to help you elevate the standard of care.
Despite advances in diagnostics, bloodstream infections (BSIs) and sepsis remain among the leading causes of death. With an estimated 49M cases globally, rapid detection and treatment are critical to improving patient outcomes.1 Fast time to detection, early antimicrobial therapy, and targeted treatment can significantly reduce mortality.2
But overcoming these infections isn’t getting easier. Hospitals and labs face growing challenges:
- Staffing shortages amongst rising workloads
- Increasing test complexity and volume
- Poor sample quality and process delays
- Financial constraints with decreasing reimbursement
- Antimicrobial resistance
To meet today’s demands, BSI diagnostics must deliver:
- Faster and more accurate detection
- Integrated weight-based blood volume measurement for all patients
- Automated vial loading and unloading to minimize unnecessary delays
- Advanced analytics to track performance of important key performance indicators (KPIs) like contamination and turnaround time
BD: Your Partner in Diagnostic Innovation
With over 50 years of leadership in microbiology and BSI diagnostics,
BD is continuing to invest in solutions that help you elevate the standard of care—today and into the future.
That’s why we’re preparing the next generation of solutions for blood culture testing.
We’ll be able to share more soon. In the meantime, learn more about our complete BSI solution available today.
What if you had an integrated bloodstream infection diagnostics solution that could enable more accurate and faster initiation of optimal therapy and expand the value of antimicrobial stewardship?
Bloodstream Infection
What if you had an integrated bloodstream infection diagnostics solution that could enable more accurate and faster initiation of optimal therapy and expand the value of antimicrobial stewardship?
References
- Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. doi:10.1016/S0140-6736(19)32989-7.
- Liu VX, Fielding-Singh V, Greene JD, et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017;196(7):856-863. doi:10.1164/rccm.201609-1848OC.